Clinical Trials Directory

Trials / Conditions / Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7

Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7

6 registered clinical trials studyying Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 — 1 currently recruiting.

StatusTrialSponsorPhase
WithdrawnNivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal C
NCT03575234
Emory UniversityPhase 1
TerminatedACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Tr
NCT02917629
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Canc
NCT02567422
National Cancer Institute (NCI)Phase 1
CompletedCisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Hea
NCT02775812
National Cancer Institute (NCI)Phase 1
CompletedOnalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Recei
NCT02381535
National Cancer Institute (NCI)Phase 1
RecruitingTesting Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy
NCT01810913
National Cancer Institute (NCI)Phase 2 / Phase 3